Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Pablo Sanchez Vela"'
Autor:
Jacqueline Tao, Pablo Sanchez Vela, Anton Safonov, Emanuela Ferraro, Sebastia Franch Exposito, Kamal Menghrajani, Ryan Ptashkin, Elizabeth Comen, Lior Z. Braunstein, Mark E. Robson, Sarat Chandarlapaty, Jorge Reis-Filho, Michael Berger, Ahmet Zehir, Larry Norton, Ross Levine, Pedram Razavi
Publikováno v:
Cancer Research. 83:P4-02
Background Clonal Hematopoiesis (CH) is a well-established risk factor for adverse clinical outcomes including all-cause mortality, cardiovascular disease, and progression to hematologic malignancies. The presence of CH has been shown to adversely im
Autor:
Robert L. Bowman, Andrew Dunbar, Tanmay Mishra, Wenbin Xiao, Michael R. Waarts, Inés Fernández Maestre, Shira E. Eisman, Louise Cai, Sheng F. Cai, Pablo Sanchez Vela, Shoron Mowla, Anthony R. Martinez Benitez, Young Park, Isabelle S. Csete, Aishwarya Krishnan, Darren Lee, Nayla Boorady, Chad R. Potts, Matthew T. Jenkins, Martin P. Carroll, Sara E. Meyer, Linde A. Miles, P. Brent Ferrell, Jennifer J. Trowbridge, Ross L. Levine
SummaryCancer evolution is a multifaceted process involving the acquisition of somatic mutations and progressive epigenetic dysregulation of cellular fate. Both cell-intrinsic mechanisms and environmental interactions provide selective pressures capa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4913080bcc50fd4a9575f5edd3e21023
https://doi.org/10.1101/2022.05.18.492524
https://doi.org/10.1101/2022.05.18.492524
Autor:
Sumit K. Chanda, Anagha Deshpande, Karina Barbosa, Ross L. Levine, Maria Kleppe, Connie J. Eaves, David A. Frank, Robert J. Wechsler-Reya, Pablo Sanchez Vela, Bo-Rui Chen, Peter D. Adams, Narayana Yeddula, Xue Lei, Soheil Meshinchi, Alexandre Rosa Campos, Ze'ev Ronai, Anindya Bagchi, Aniruddha J. Deshpande, Scott A. Armstrong, Irmela Jeremias, Torsten Haferlach
Publikováno v:
Blood
Blood 137, 3403-3415 (2021)
Blood 137, 3403-3415 (2021)
Leukemias bearing fusions of the AF10/MLLT10 gene are associated with poor prognosis, and therapies targeting these fusion proteins (FPs) are lacking. To understand mechanisms underlying AF10 fusion-mediated leukemogenesis, we generated inducible mou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799461229e544438fc2b882bc0ea2ae3
https://europepmc.org/articles/PMC8212510/
https://europepmc.org/articles/PMC8212510/
Autor:
Jacqueline Tao, Jeremy Setton, Pablo Sanchez Vela, Anton Mikhailovich Safonov, Elizabeth Anne Comen, Lior Zvi Braunstein, Jorge S. Reis-Filho, Nadeem Riaz, Simon N. Powell, Ross L. Levine, Larry Norton, Atif J. Khan, Pedram Razavi
Publikováno v:
Journal of Clinical Oncology. 40:3145-3145
3145 Background: Clonal hematopoiesis (CH) has well established associations with adverse clinical outcomes including all-cause mortality, cardiovascular disease, and progression to hematologic malignancy. The presence of CH has also been demonstrate
Autor:
Shira E. Eisman, Tanmay Mishra, Robert L. Bowman, Jennifer J. Trowbridge, Paul Brent Ferrell, Ross L. Levine, Matthew T. Jenkins, Wenbin Xiao, Chad R. Potts, Michael R. Waarts, Inés Fernández-Maestre, Louise Cai, Isabelle S. Csete, Pablo Sanchez Vela, Linde A. Miles
Publikováno v:
Blood. 138:2220-2220
Genomic studies in acute myeloid leukemia (AML) have generated a near complete catalogue of genes mutated at varying frequencies both across patients and in individual leukemias. The high variability of mutation burden within a given leukemia is sugg
Autor:
Pablo Sánchez Velarde
Publikováno v:
Derecho PUCP, Iss 46 (1992)
No contiene resumen
Externí odkaz:
https://doaj.org/article/ce095602d3234492b520f9b32fca563e